Lessons learned from attempts to establish the blind in placebo-controlled trials of zinc for the common cold

Annals of Internal Medicine

Volumn 133, Issue 4, 2000, Pages 302-303

  Desbiens, N A ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; ZINC;

CLINICAL RESEARCH; CLINICAL TRIAL; COMMON COLD; DATA ANALYSIS; DRUG EFFICACY; EDITORIAL; HUMAN; PATIENT SELECTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034662961     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-133-4-200008150-00016     Document Type: Editorial

References (6)

1. The problems of taste in placebo matching: An evaluation of zinc gluconate for the common cold
2. The history of the double-blind procedure
3. Powerful placebo: The dark side of the randomised controlled trial
4. Placebo effect and placebo concept: A critical methodological and conceptual analysis of reports on the magnitude of the placebo effect
5. Double blind: Double talk or are there ways to do better research
6. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial